www.fdanews.com/articles/146793-gsk-melanoma-combination-drug-takes-on-roche-rsquo-s-zelboraf-in-phase-iii-trial

GSK Melanoma Combination Drug Takes on Roche’s Zelboraf in Phase III Trial

May 30, 2012

GlaxoSmithKline stirred up cancer circles this month when release of some clinical data of its melanoma treatment suggested that the experimental combination drug could work better than Roche’s Zelboraf.
MedCity News